Literature DB >> 8702432

Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat.

M Iida1, T Murakami, K Ishida, A Mizuno, M Kuwajima, K Shima.   

Abstract

We recently cloned one of spliced variant forms of rat leptin receptor (OB-R), which contains a short intracellular domain, and found obese-phenotype-linked nucleotide alteration in the extracellular domain of the cDNA from the Zucker (fa/fa) rat, which results in a glutamine269 to proline269 amino acid substitution. Reported herein are the cloning and sequencing of another spliced variant forms of rat OB-R cDNA with a long intracellular domain. Both forms of OB-R cDNA share the same extracellular domain. In the Zucker (fa/fa) rat, no changes in either the gene structure nor in the nucleotide sequence of the long intracellular domain were observed. However, the expression level of OB-R mRNA in the brain of Zucker (fa/fa) rat was higher than for lean littermates. These facts suggest that the substitution at codon 269 of the OB-R cDNA represents the crucial mutation which results in the obese phenotype of Zucker (fa/fa) rat.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702432     DOI: 10.1006/bbrc.1996.1070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

Review 1.  Molecular basis of the obesity associated with Bardet-Biedl syndrome.

Authors:  Deng-Fu Guo; Kamal Rahmouni
Journal:  Trends Endocrinol Metab       Date:  2011-04-21       Impact factor: 12.015

2.  Impaired in vivo venous constriction in conscious obese Zucker rats with metabolic syndrome.

Authors:  Dongzhe Song; Simon R Hutchings; Catherine C Y Pang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-31       Impact factor: 3.000

3.  Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.

Authors:  M Shimabukuro; K Koyama; Y Lee; R H Unger
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 4.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament.

Authors:  Yoshikazu Ikeda; Arata Nakajima; Atsuomi Aiba; Masao Koda; Akihiko Okawa; Kazuhisa Takahashi; Masashi Yamazaki
Journal:  Eur Spine J       Date:  2011-01-22       Impact factor: 3.134

6.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

7.  Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

8.  Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors.

Authors:  K Koyama; M Shimabukuro; G Chen; M Y Wang; Y Lee; P S Kalra; M G Dube; S P Kalra; C B Newgard; R H Unger
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 9.  Cardiovascular disease in the JCR:LA-cp rat.

Authors:  J C Russell; S E Graham; M Richardson
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Development of attenuated baroreflexes in obese Zucker rats coincides with impaired activation of nucleus tractus solitarius.

Authors:  Priscila S Guimaraes; Domitila A Huber; Maria J Campagnole-Santos; Ann M Schreihofer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-26       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.